Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: GlobeNewswire
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a top-tier shareholder rights firm, is investigating Abbott’s proposed $21 billion acquisition of Exact Sciences Corp. (NASDAQ: EXAS). Julie & Holleman has already identified conflicts and believes the $105 per share deal price may be too low. For a free consultation, please visit https://julieholleman.com/exact-sciences-corp/, or contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com. The deal was announced in November and is expected to close in the second quarter of 2026. On December 29, 2025, Exact Sciences filed a preliminary proxy statement with the SEC in connection with the upcoming shareholder vote on the merger. The proxy statement reveals a process where no other bidders were considered. Moreover, one of the company’s financial advisors indicated that Exact Sciences could be worth as much as $136.25 per share. Julie & Holleman, whose attorneys have helped secure hundreds
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics [Seeking Alpha]Seeking Alpha
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 1/9/26 - Form DEFM14A
- 12/30/25 - Form 4
- 12/30/25 - Form 4
- EXAS's page on the SEC website